US House adopts patent reform, but fee change could be trouble for Senate
This article was originally published in RAJ Devices
After several years of failed attempts to make US patent reform a reality, the Senate is now faced with either adopting legislation passed by the House that would require funding for the US Patent & Trademark Office (US PTO) to continue to be appropriated by Congress or engaging in a battle that could upend any chances of getting a law enacted this year.
You may also be interested in...
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.